Synthesis of molnupiravir (MK-4482, EIDD-2801): a promising oral drug for the treatment of COVID-19 starting from cytidine
- 6 December 2022
- journal article
- research article
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 42 (6) , 427-435
Abstract
The present work describes the synthesis of molnupiravir by employing commercially available inexpensive materials in two steps with an overall yield of 85.7%. The synthetic methodology starts with an eco-friendly starting material, that is, cytidine and establishes an alternative way to avoid costly enzyme mediated reactions. This synthetic strategy involves a selective acylation of cytidine as the first key step followed by the second step, that is, hydroxamination reaction. The major advantage of this protocol is that it is completely free of protection and deprotection reactions. Chemoselective acylation of cytidine's primary alcohol was achieved using isobutyryl chloride, Et3N, and DMF solvent (89.3% yield). The aqueous phase transformation was achieved for the hydroxamination reaction with a 96% yield.Keywords
This publication has 20 references indexed in Scilit:
- Ribose Moieties Acylation and Characterization of Some Cytidine AnalogsJournal of Siberian Federal University. Chemistry, 2020
- A High‐Yielding Synthesis of EIDD‐2801 from Uridine**European Journal of Organic Chemistry, 2020
- A concise route to MK-4482 (EIDD-2801) from cytidineChemical Communications, 2020
- A Concise Route to MK-4482 (EIDD-2801) from Cytidine: Part 2Synlett, 2020
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in miceScience Translational Medicine, 2020
- Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epitheliaScience Translational Medicine, 2019
- An Efficient Synthesis of the bis-Tetraazacyclodecane JM3100 Under PTC ConditionsOrganic Preparations and Procedures International, 2018
- Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesAntimicrobial Agents and Chemotherapy, 2018
- An efficient practical tosylation of phenols, amines, and alcohols employing mild reagent [DMAPTs] + Cl −Tetrahedron Letters, 2016
- Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancerMolecular Cancer Therapeutics, 2006